A Practical Approach to Building Diversity into Clinical Trials Using Purpose-Built Sites
Achieving diversity in clinical trials is critical to ensuring safe, effective therapies and equitable health outcomes, as well as fostering […]
Overcoming Recruitment Challenges in the Current Vaccine Boom
As the vaccine industry advances, recruiting participants for clinical trials becomes more complex. Clinical development professionals face challenges such as
Tackling High Screen Failure Rates and Boosting Diversity in CNS Clinical Trials
High screen failure rates in central nervous system (CNS), neurological, and psychiatric clinical trials are among the most significant barriers
CNS Summit Poster Presentation: Enhancing Access and Diversity with Purpose-Built Study Sites
Background The U.S. Food and Drug Administration (FDA) is actively seeking diversity in clinical trials. While Caucasians represent 58% of
Alliance Clinical Welcomes Peter Beardsley as Chief Commercial Officer
Southlake, Texas, September 6, 2024: Today, Alliance Clinical Network announced that Peter Beardsley will join the company as Chief Commercial
Ensuring Diversity in Clinical Trial Enrollment: A Mandate for Change
4 Minute Read Clinical trials—and the sites where these studies are conducted—exist to prove the safety and efficacy of therapies
Prioritizing Diversity in Vaccine Clinical Trials: 5 Strategies for Success
5 Minute Read Clinical trial diversity is essential to ensure novel therapeutics are effective and safe for the populations they
Overcoming Challenges in Obesity Clinical Trials: A Patient-Centric Approach
5 Minute Read Obesity is a growing global health issue, with its prevalence reaching epidemic proportions. Affecting more than one